SEPN — Septerna, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1984086 ·
Last close
$40.52
Market Cap
$1.89B
52W High
$51.10
52W Low
$27.08
ADV30
405,692
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 26,523,000 | — | -13,300,000 | -8,637,000 | 569,688,000 | 71,605,000 | 191,230,000 |
| Dec 2025 | 24,118,000 | — | -16,023,000 | -10,738,000 | 596,187,000 | 120,722,000 | 214,261,000 |
| Sep 2025 | 21,495,000 | — | -9,886,000 | 8,173,000 | 606,653,000 | 319,989,000 | 217,922,000 |
| Jun 2025 | 119,000 | — | -28,978,000 | -24,838,000 | 415,231,000 | 189,311,000 | 37,674,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$107,899,000
Investing CF
$-248,295,000
Financing CF
$1,956,000
CapEx
$-968,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.81
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-175,890,000
Inventory
—
Receivables
$14,290,000
ST Investments
$275,796,000
EBIT TTM
$-68,187,000
Pretax Income TTM
$-35,691,000
Interest Exp TTM
—
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$98,882,000
EBITDA
$-54,395,000
Free Cash Flow
$29,544,876
Enterprise Value
$1,517,300,864
Total Cash
$372,321,984
Total Debt
$22,545,000
Shares Out
46,676,947
Trailing EPS
$-0.53
Book Value
$8.43
ROE
-6.3%
ROA
-7.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 45,951,000 | -80,797,000 | -48,879,000 | 596,187,000 | 214,261,000 | — | 110,189,000 |
| Dec 2024 | 1,075,000 | -80,823,000 | -71,798,000 | 456,554,000 | 36,507,000 | — | -67,470,000 |
| Dec 2023 | 151,000 | -45,550,000 | 4,180,000 | 130,867,000 | 169,241,000 | — | -38,723,000 |
| Dec 2022 | 0 | -27,967,000 | -27,676,000 | 36,119,000 | 80,320,000 | — | -23,303,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.94
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $45.00 · spot: $40.52 · call volume: 5 · put volume: 243Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HMDCF | HUTCHMED (China) Ltd | $1.88B | $2.16 | — |
| DMRA | Damora Therapeutics, Inc. | $1.87B | $30.31 | — |
| SRPT | Sarepta Therapeutics, Inc. | $1.92B | $18.13 | — |
| GHRS | GH Research PLC | $1.93B | $28.10 | — |
| ETON | Eton Pharmaceuticals, Inc. | $1.84B | $64.43 | — |
News headlines (Yahoo Finance, 1h cache)
Septerna, Inc. (SEPN) Reports Q2 Loss, Beats Revenue Estimates
2026-08-10 21:10 · Yahoo
Septerna's Chief People Officer Sold Nearly 12,000 Company Shares. What Does That Mean for Investors?
2026-07-05 13:55 · Yahoo
Is Septerna, Inc. (SEPN) Stock a Biotech Opportunity With a Potential First-in-Class Hypoparathyroidism Treatment?
2026-07-02 19:58 · Yahoo
Is Septerna a Stock to Sell After an Insider Let Go of 15,000 Shares?
2026-06-30 03:25 · Yahoo
Protego Biopharma Appoints Jae B. Kim, MD, as Chief Medical Officer
2026-06-08 11:00 · Yahoo
Party Time: Brokers Just Made Major Increases To Their Septerna, Inc. (NASDAQ:SEPN) Earnings Forecasts
2026-05-17 14:47 · Yahoo
Septerna, Inc. (SEPN) Reports Q1 Loss, Tops Revenue Estimates
2026-05-11 21:25 · Yahoo
Septerna Highlights Business Progress and Reports First Quarter 2026 Financial Results
2026-05-11 20:01 · Yahoo
How Analyst Upgrade and Conference Spotlight Will Impact Septerna (SEPN) Investors
2026-05-08 13:19 · Yahoo
Septerna to Present at Bank of America Securities Health Care Conference
2026-05-05 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.